IVF Success Rates by Age: 2026 Data

IVF Success Rates by Age: 2026 Data

Understanding how age affects IVF success rates is one of the most important steps for anyone considering international surrogacy or fertility treatment. The numbers tell a clear story: age is the single strongest predictor of IVF outcomes. This guide brings together the latest 2026 clinical data from leading fertility clinics and registries worldwide, broken down by age group, diagnosis, and embryo type.

Why Age Matters in IVF: The Biological Basics

Female age affects IVF success primarily through egg quality and quantity. Women are born with all the eggs they will ever have—roughly 1–2 million at birth, declining to about 300,000 by puberty, and dropping more steeply after age 35. But it is not just quantity. The percentage of chromosomally normal (euploid) embryos falls steadily with age:

• Age 25–29: Approximately 50–60% of embryos are euploid
• Age 30–34: Approximately 40–50% are euploid
• Age 35–37: Approximately 30–40% are euploid
• Age 38–40: Approximately 20–30% are euploid
• Age 41–42: Approximately 10–15% are euploid
• Age 43+: Less than 5% are euploid

This biological reality shapes every stage of the IVF journey—from stimulation response and egg retrieval to fertilization, blastulation, and ultimately live birth rates.

IVF Success Rates by Age Group: 2026 Data

The following data reflects aggregated 2024–2025 clinic results reported to global IVF registries, published in early 2026. Rates are presented as live birth per embryo transfer—the most meaningful metric for patients.

Age 25–29: The Peak Years

Women under 30 represent the highest-success population in IVF. In 2026, clinics reported:

• Fresh embryo transfer (own eggs): 45–55% live birth rate per transfer
• Frozen embryo transfer (own eggs): 50–60% live birth rate per transfer
• PGT-A screened (euploid) embryos: 65–75% live birth rate per transfer

The difference between fresh and frozen outcomes reflects both embryo selection (freezing allows time for genetic testing) and the fact that a “freeze-all” strategy avoids transferring embryos in a cycle where the uterine environment may have been affected by high hormone levels during stimulation.

Age 30–34: Still Strong, Slight Decline

This age group remains highly favorable for IVF. 2026 data shows:

• Fresh embryo transfer (own eggs): 40–48% live birth rate per transfer
• Frozen embryo transfer (own eggs): 45–55% live birth rate per transfer
• PGT-A screened (euploid) embryos: 60–70% live birth rate per transfer

At this age, many patients still achieve pregnancy within 1–2 IVF cycles. The cumulative live birth rate after three cycles exceeds 80% for most patients in this group.

Age 35–37: The First Major Turning Point

Age 35 is widely recognized as the point where fertility decline becomes more pronounced. 2026 data:

• Fresh embryo transfer (own eggs): 30–38% live birth rate per transfer
• Frozen embryo transfer (own eggs): 35–45% live birth rate per transfer
• PGT-A screened (euploid) embryos: 55–65% live birth rate per transfer

The gap between untested and PGT-A screened embryos widens in this age group, making genetic screening more valuable for reducing miscarriage risk and improving per-transfer success.

Age 38–40: Accelerated Decline

Success rates drop more sharply here. 2026 data:

• Fresh embryo transfer (own eggs): 20–28% live birth rate per transfer
• Frozen embryo transfer (own eggs): 22–32% live birth rate per transfer
• PGT-A screened (euploid) embryos: 45–55% live birth rate per transfer

The substantial boost from PGT-A screening is most evident in this age group. Because the aneuploidy rate is high, transferring only screened normal embryos can nearly double the chance of live birth compared to untested embryos.

Age 41–42: Low but Not Zero

IVF with own eggs at age 41–42 has low but measurable success. 2026 data:

• Fresh embryo transfer (own eggs): 10–15% live birth rate per transfer
• Frozen embryo transfer (own eggs): 12–18% live birth rate per transfer
• PGT-A screened (euploid) embryos: 35–45% live birth rate per transfer

However, the number of euploid embryos available per retrieval is typically very low (often zero or one). Most clinics recommend considering donor eggs at this stage.

Age 43 and Above: Donor Eggs Recommended

With own eggs, live birth rates per transfer at age 43+ are typically below 5% in 2026 data. The story changes dramatically with donor eggs:

• IVF with donor eggs (age of donor < 35): 55–70% live birth rate per transfer
• Cumulative live birth (2–3 donor egg cycles): Over 90%

Donor Eggs: Reversing the Age Effect

One of the most important insights from 2026 data is that egg donor age—not recipient age—determines embryo quality. When a 45-year-old woman receives an embryo created from a 26-year-old donor’s eggs, her success rates mirror those of a 26-year-old patient.

This is why Georgia surrogacy and other international programs increasingly pair older intended mothers with donor egg cycles. The data is clear:

• Donor egg IVF success rates have remained stable at 60–70% per transfer for the past five years
• Recipient age (up to approximately age 50) has minimal impact on uterine receptivity
• Miscarriage rates with donor eggs are similar to those of the donor’s age group (10–15%) rather than the recipient’s age (which would be 30–50% with own eggs at age 45)

Male Age and IVF Success: What 2026 Data Shows

While female age dominates the conversation, 2026 research continues to refine our understanding of paternal age effects. Key findings:

• Sperm DNA fragmentation increases with male age (especially 45+), potentially affecting embryo development and pregnancy loss
• Pregnancy rates are less affected by male age than female age, but miscarriage risk shows a slight increase when the male partner is over 45
• PGT-A testing helps filter out some age-related sperm DNA issues, as aneuploid embryos are less likely to implant or more likely to miscarry naturally

For older male partners, clinics in 2026 increasingly recommend sperm DNA fragmentation testing and, when indicated, testicular sperm extraction (TESE), which can yield sperm with lower fragmentation rates than ejaculated sperm.

IVF Success by Diagnosis: Age-Adjusted Data

Success rates also vary by diagnosis. The 2026 data, age-adjusted for the 35–39 bracket:

• Male factor infertility: Success rates are generally comparable to unexplained infertility when ICSI (intracytoplasmic sperm injection) is used
• Endometriosis (Stage III/IV): Live birth rates are approximately 5–10 percentage points lower than tubal factor infertility, largely due to reduced ovarian reserve
• PCOS (Polycystic Ovary Syndrome): Younger PCOS patients (under 35) often have higher-than-average egg yield, but freeze-all strategies are recommended to avoid OHSS (ovarian hyperstimulation syndrome)
• Repeated implantation failure (RIF): After three failed transfers, success rates per subsequent transfer drop to 15–25% without additional intervention (ERA testing, immune protocols)

How Clinic Choice Affects Your Success Rates

Not all clinics perform equally. 2026 data from the best-performing clinics (top decile) shows they consistently achieve results 10–15 percentage points above national averages. Factors that distinguish high-performing clinics include:

• Lab quality: Embryology lab conditions (air quality, temperature stability, culture media) account for a significant portion of outcome differences
• Embryo biopsy timing: Clinics that routinely biopsy on day 5/6 (trophectoderm biopsy) for PGT-A achieve more reliable results than those using day 3 biopsies
• Elective single embryo transfer (eSET) policies: Top clinics achieve high success rates with single embryo transfers, reducing twin risks without sacrificing cumulative live birth rates
• Experience with international patients: Clinics familiar with IVF process for international parents have better outcomes because they coordinate travel, medication, and timing more effectively

Cumulative Success: How Many Cycles Do You Need?

Per-transfer rates tell only part of the story. The cumulative live birth rate (CLBR) after multiple cycles is what most patients actually experience. 2026 data:

• Age 30, own eggs: After 1 cycle: ~45%; after 2 cycles: ~70%; after 3 cycles: ~85%
• Age 35, own eggs: After 1 cycle: ~35%; after 2 cycles: ~55%; after 3 cycles: ~70%
• Age 40, own eggs: After 1 cycle: ~22%; after 2 cycles: ~35%; after 3 cycles: ~45%
• Age 43+, donor eggs: After 1 cycle: ~65%; after 2 cycles: ~85%; after 3 cycles: ~95%

These numbers underscore why many clinics now offer package pricing for multiple cycles—and why patients over 40 are often counseled to consider donor eggs or surrogacy after one or two unsuccessful own-egg cycles.

Frequently Asked Questions

What is a “good” IVF success rate in 2026?

A good benchmark depends entirely on your age. For a 32-year-old using her own eggs, a clinic reporting 50%+ live birth per transfer is performing well. For a 41-year-old using her own eggs, a 15% rate is within the normal range. Always compare your specific age group—not the clinic’s overall average, which may be skewed by treating younger patients.

Do PGT-A tested embryos guarantee pregnancy?

No. While PGT-A screening significantly improves per-transfer success rates by selecting chromosomally normal embryos, it cannot eliminate all risks. Even with a euploid embryo, factors such as endometrial receptivity, immune issues, and implantation window timing affect outcomes. However, the data consistently shows 60–70% live birth rates with euploid embryos for patients under 35.

How does BMI affect IVF success rates by age?

BMI affects success at every age, but the effect is most pronounced in patients over 35. A BMI over 30 is associated with 5–10% lower live birth rates, higher miscarriage rates, and increased risk of OHSS in young patients. Weight optimization before starting IVF is one of the few modifiable factors that can meaningfully improve outcomes.

Is it worth doing IVF at age 44 with own eggs?

The data suggests most patients over 43 have a less than 2% chance of live birth per own-egg cycle. While there are occasional successes, the financial and emotional cost of repeated attempts is substantial. Most reproductive endocrinologists recommend moving to donor eggs, which offer a 60–70% per-transfer success rate regardless of recipient age (up to approximately age 50).

How do success rates compare between fresh and frozen transfers?

In 2026, frozen embryo transfers (FET) slightly outperform fresh transfers for most age groups—by approximately 5–10 percentage points. This is partly because FET allows time for PGT-A testing and partly because the uterine environment in a natural or programmed cycle is often more receptive than in a stimulated cycle. The gap is narrowing as clinics improve their fresh transfer protocols.

Conclusion: What the 2026 Data Means for You

The central takeaway from 2026 IVF data is that age remains the most powerful predictor of success—but it is not the only one. Donor eggs can effectively reset the age clock. PGT-A screening can significantly improve per-transfer odds. Clinic choice matters. And for patients who cannot achieve pregnancy with their own eggs at an advanced age, Kenya surrogacy and other international pathways offer proven alternatives with high success rates.

If you are considering IVF or surrogacy, the most valuable step you can take is to get age-specific data from a clinic that publishes its own results—not just national averages. Your individual chances depend on your specific profile, and the right clinic will give you an honest, data-backed assessment.

This article was last updated in June 2026 with the most recent clinical data available. Success rates are presented as live births per embryo transfer unless otherwise noted. Individual results may vary based on diagnosis, clinic, and personal health factors.